2 recruiting, 1 not yet recruiting. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Recruiting 2, Not yet recruiting 1 |
Follow efgartigimod alfa: new trials by email Literature Review of efgartigimod alfa trials Research Report on efgartigimod alfa
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate the Benefit of Corticoid Sparing in Elderly With Generalized AntiRAch Myasthenia Gravis Treated With IV or SC Efgartigimod Efgartigimod - Myasthenia Gravis, Generalized | Phase 4 | Recruiting | Centre Hospitalier Universitaire de Nice | 50 | 2025-09-19 | 2026-09-03 |
| Treatment of Myasthenia Gravis Exacerbation or Crisis With Efgartigimod Efgartigimod - Myasthenia Gravis Crisis, Myasthenia Gravis Exacerbations | Phase 4 | Recruiting | University of Colorado, Denver | 20 | 2025-03-06 | 2025-07-11 |
| Intravenous Human IgG1 Fc Fragment (Efgartigimod) in Myasthenic Crisis IV efgartigimod - Myasthenia Gravis Crisis | Phase 4 | Not yet recruiting | Rambam Health Care Campus | 16 | 2024-11-15 | 2024-11-14 |
Centre Hospitalier Universitaire de Nice (1) · Rambam Health Care Campus (1) · University of Colorado, Denver (1)
France (1) · Israel (1) · United States (1)